PERTH, Australia, Dec. 11, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has entered into a research agreement with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids.
Tag Archives: autism
Autism, Sleep Apnea Added to Minnesota List for Medical Marijuana
Minnesotans with autism and obstructive sleep apnea will be able to use medical marijuana as of next July to manage their medical conditions.
Israel Wants to Start Exporting Its Cannabis Around the World
When Asi Naim, a severely autistic Israeli boy, started smacking his head against the wall and hurting himself in other ways, his parents tried every kind of psychiatric drug to calm him. Nothing worked. Then Asi entered a cannabis-based research program at Jerusalem’s Shaarei Zedek hospital.
Minnesota Medical Marijuana Officials Debate Adding Autism to List
Medical pot has been legal in Minnesota for more than two years, treating thousands of people and the panel in charge of overseeing the program will consider adding new conditions and diseases to the list.
Pennsylvanian Research University Wants to Conduct Medical Cannabis Autism Study
While Pennsylvania is processing hundreds of medical cannabis business applications, one private Pennsylvanian research university is already making plans to conduct a medical cannabis autism study.
Clinical Research Programme to Expand to Include Autism Spectrum Disorder
PERTH, Australia, April 19, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its clinical trial programme in Chile to include autism.
Georgia House Approves Medical Marijuana Expansion Bill
On March 1, 2017, the Georgia House of Representatives voted to approve House Bill 65, which would expand the number of qualifying conditions covered by the state’s limited medical marijuana program.
Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™
SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States subsidiary, HempMeds® Brasil, today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).
Georgia Lawmakers Hope to Expand Medical Cannabis
For years, Georgia lawmakers have debated the merits of medical marijuana and the discussion will continue this year.
South Carolina Lawmakers Introduce Medical Marijuana Bill
On Jan. 10, 2017, a bipartisan group of South Carolina lawmakers, led by Sen. Tom Davis, introduced a bill to the state Senate to legalize the cultivation, sale and consumption of medical marijuana for patients suffering from certain debilitating medical conditions.
Minnesota Adds PTSD as Qualifying Condition for Medical Marijuana
Minnesota residents suffering from post-traumatic stress disorder will soon be able to use medical marijuana to treat their condition.
More Conditions May Expand Medical Marijuana in Minnesota
The Minnesota’s Department of Health was expected to announce Thursday whether it would expand the program to people suffering post-traumatic stress disorder, autism, arthritis and others.
New Jersey Seeks Public Input on Medical Marijuana
If you have a medical condition that could possibly be treated with medical marijuana, the state of New Jersey wants to hear from you.
Georgia GOP State Convention Endorses Cannabis Oil Resolution
On June 4, 2016, a cannabis oil resolution was endorsed by the Georgia GOP State Convention in Augusta. The resolution requires that the Georgia General Assembly figure out how parents in Georgia can access cannabis oil, which was legalized in the state on March 27, 2015.
Illinois to Consider Adding Conditions to Medical Cannabis Program
On Monday, May 2, 2016, the Illinois Medical Cannabis Advisory Board will meet to discuss the possibility of approving additional conditions for the state’s list of conditions that can qualify a patient to use medical cannabis.
Pennsylvania House Approves Medical Marijuana Bill
On March 16, 2016, the Pennsylvania House of Representatives voted to approve SB 3, a bill legalizing medical marijuana in the state.
Georgia Lawmaker Makes Final Effort to Expand Medical Marijuana Law
In Georgia, a state lawmaker is making a last ditch effort to expand the state’s medical marijuana laws.
Cannabis Science Targets Successful Autism Treatments and Brings Family Autism Advocate Mieko Hester-Perez on Its Scientific Advisory Board
COLORADO SPRINGS, Colo., Feb. 8, 2016/ Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced its next critical ailment target is autism and brings Mieko Hester-Perez on its Scientific Advisory Board to lead this charge.
Michigan Rejects Adding Autism to Qualifying Conditions
Autism will not be added to Michigan’s list of qualifying conditions for medical marijuana. Although there has been a growing movement of parents campaigning for the condition to be added, the decision ultimately rested with Mike Zimmer.
Michigan Board Recommends Adding Autism to Qualifying Conditions
On July 31, 2015, with a vote of 4-2, the Michigan Medical Marijuana Review Panel voted to recommend that autism be added to the list of qualifying conditions for medical marijuana treatment.
Autism Alleviated With Cannabis
On May 3, 2014, Medical Daily reported that one parent used specialized strain of cannabis to successfully treat her son’s autism and muscular dystrophy.